In SLE, greater proportions of highly cytotoxic and proinflammatory activated CD8+ T cells in peripheral blood-modulated disease activity, organ damage and residual treatment resistance, presenting a potential treatment target. Here, CD8A is linked to systemic lupus erythematosus.